CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
1.014
-0.046 (-4.33%)
Apr 7, 2026, 4:00 PM EDT - Market closed
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $11.7 million as of April 7, 2026. Its market cap has decreased by -61.47% in one year.
Market Cap
11.70M
Enterprise Value
10.45M
1-Year Change
-61.47%
Ranking
Category
Stock Price
$1.01
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $11.70M, a decrease of -74.62%. That is a compound annual growth rate of -36.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 12.23M | -20.60% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genprex | 13.12M |
| BioCardia | 12.91M |
| Kairos Pharma | 12.91M |
| Biodexa Pharmaceuticals | 12.54M |
| Moleculin Biotech | 12.38M |
| Jupiter Neurosciences | 12.37M |
| Chemomab Therapeutics | 11.95M |
| Soligenix | 11.75M |